I-Mab Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $28.69 | $1.59 B | -7.1 | 61 | $0 |
 APLS
|
Apellis Pharmaceuticals, Inc. | $28.80 | $4.90 B | -11.77 | 702 | $396.59 M |
 ASND
|
Ascendis Pharma A/S | $149.12 | $7.77 B | -14.19 | 879 | $266.72 M |
 BGNE
|
BeiGene, Ltd. | $224.77 | $17.07 B | -20.76 | 10000 | $2.46 B |
 BPMC
|
Blueprint Medicines Corporation | $92.51 | $6.47 B | -21.48 | 638 | $249.38 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.73 | $1.29 B | -7.16 | 85 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.39 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.72 | $647.94 M | -2.83 | 126 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $9.33 | $332.53 M | -2.73 | 116 | $34.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.29 | $243.38 M | -1.59 | 129 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 IMVT
|
Immunovant, Inc. | $28.50 | $3.68 B | -13.39 | 207 | $0 |
 KRYS
|
Krystal Biotech, Inc. | $181.83 | $4.70 B | 75.42 | 229 | $50.70 M |
 KYMR
|
Kymera Therapeutics, Inc. | $47.31 | $2.02 B | -13.13 | 181 | $78.59 M |
 LYEL
|
Lyell Immunopharma, Inc. | $1.38 | $619.50 M | -2.7 | 224 | $130,000 |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 NRIX
|
Nurix Therapeutics, Inc. | $22.51 | $930.10 M | -5.89 | 284 | $76.99 M |
 RVMD
|
Revolution Medicines, Inc. | $45.34 | $6.66 B | -10.51 | 443 | $11.58 M |
 STTK
|
Shattuck Labs, Inc. | $3.48 | $333.81 M | -3.64 | 75 | $1.66 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |